Key result
High SYNTAX scores linked to ~222% higher 1-year risk of major events versus low scores.
Why the study?
The validity of the SYNTAX score and clinical SYNTAX score in predicting outcomes after PCI with unrestricted use of limus-eluting stents has not been fully investigated in daily practice.
Do the SYNTAX score and clinical SYNTAX score predict 1-year clinical outcomes in patients receiving unrestricted use of sirolimus- and everolimus-eluting stents?
Cohort (n=5,102)
Yes
Do the SYNTAX score and clinical SYNTAX score predict 1-year clinical outcomes in patients receiving unrestricted use of sirolimus- and everolimus-eluting stents?
Both the SYNTAX score and clinical SYNTAX score are valid predictors of 1-year clinical outcomes in patients treated with sirolimus- and everolimus-eluting stents in daily practice.
Answers are grounded in this paper and cite their sources.
May support SYNTAX-based risk stratification after DES; extends validation to sirolimus- and everolimus-eluting stents but should not yet change practice.
BACKGROUND: The SYNTAX score (SS) and clinical SS (cSS) can assess coronary lesion complexity and are useful indices in predicting outcomes after percutaneous coronary intervention. However, their validity has not been fully investigated in daily practice where "limus"-eluting stents are used. METHODS AND RESULTS: The SS and cSS were independently assessed from the Efficacy of Xience/Promus vs. Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry, together with the 1-year patient-oriented composite endpoint (POCE; all-cause death, any myocardial infarction (MI), and any revascularization) and target-lesion failure (TLF; cardiac death, target-vessel MI, and target-lesion revascularization). Among 5,102 patients, tertiles for SS were defined as low-SS <8, 8≤mid-SS≤16, high-SS >16. Both POCE (4.2% vs. 7.7% vs. 12.2%, P<0.001) and TLF (1.6% vs. 2.4% vs. 4.5%, P<0.001) increased significantly with increasing SS tertile, and SS was an independent predictor of POCE (P<0.001 for trend) and TLF (P=0.023 for trend) in multivariate analysis. The predictability of SS and cSS was similar for POCE (area under the curve (AUC): 0.635 vs. 0.629, P=0.599), whereas SS was superior in predicting restenosis-related outcomes such as revascularization (AUC: 0.624 vs. 0.577, P<0.001) and cSS was superior in other components such as death (AUC: 0.654 vs. 0.795, P<0.001). CONCLUSIONS: Both SS and cSS were applicable to unrestricted use of "limus"-eluting stents in predicting the risk of 1-year clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Park et al. (2013) conducted a cohort in Coronary artery disease (n=5,102). High SYNTAX score (>16) vs. Low SYNTAX score (<8) was evaluated on Patient-oriented composite endpoint (POCE: all-cause death, any myocardial infarction, and any revascularization) (HR 3.221, 95% CI 2.175-4.769, p=<0.001). Higher SYNTAX scores (>16) were associated with an increased 1-year risk of the patient-oriented composite endpoint compared to low scores (<8).
Synapse has enriched 10 related papers. Consider them for comparative context: